英文别名 |
cefetametpivoxil hydrochloride;Cefetamet;(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;CEFETAMET PIVOXIL HCL;Cefotaxime Sodium EP Impurity A;Cefetamet acid;Cefetamet hydrochloride;Cefetametum;CEMT;Deacetoxycefotaxime;(6R,7R)-7-[[(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrochloride;Cefotaxime impurity A;Cefotaxime EP impurity A;(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime);3-methyl-7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid;D03424;CEFETAMET [USAN];Cefetametum [Latin];Cefetamet (USAN/INN);CHEBI:135629;CEFOTAXIME IMPURITY A [EP IMPURITY];LY-97964;Ro 15-8074;UNII-4R5TV783X3;MFCD00870989;DTXSID00867110;Cefetamet acid;Cefetamet;Deacetoxycefotaxime;Cefetamet [USAN:INN];LY097964;CEFOTAXIME SODIUM IMPURITY A [EP IMPURITY];65052-63-3;HY-A0111;4R5TV783X3;CEFETAMET [INN];(6R,7R)-7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)ethanoyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, AldrichCPR;CEFETAMET [USP-RS];(6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;AS-33463;CEFETAMET [WHO-DD];CEFETAMET [USP IMPURITY];MFCD00864836;SCHEMBL65620;FR 13300;AKOS015898798;(6R,7R)-7-(((2Z)-2-(2-AMINOTHIAZOL-4-YL)-2-(METHOXYIMINO)ACETYL)AMINO)-3-METHYL-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID;CEFETAMET [MART.];(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Ro-15-8074;Deacetoxycefotaxime, 97%;CHEMBL2103764;CS-0014040;DB13504;CEFETAMET [MI];LY-097964;Cepime O;DA-51747;BRD-K27798832-001-01-5 |